More Information

Tina J. Kanmaz, Pharm.D.

Associate Professor
Associate Clinical Professor
Pharm.D., Pharmacy, St. John's University
BS, Pharmacy, St. John's University
BA, Biology, Hofstra University
Dr. Kanmaz has served on the faculty at St. John's University, College of Pharmacy and Health Professions since 1996 with an interim three-year appointment as an HIV Clinical Science Manager at Abbott Laboratories. She is currently the Assistant Dean for Experiential Pharmacy Education and Associate Clinical Professor in the Department of Clinical Health Professions. She has received several grants directed toward the care of patients with HIV/AIDS and disadvantaged persons in high poverty situations. She is certified as an American Academy of HIV Medicine HIV Expert as well as a certified Smoking Cessation Counselor. Dr. Kanmaz has provided leadership to several internal committees and on the Accreditation Council for the Pharmacy Education Steering Committee. She is a Senior Vincentian Research Fellow from the Class of 2010. Dr. Kanmaz is also an active member of several committees within the American Association of Colleges of Pharmacy Experiential Education Special Interest Group.

Research Interests

Interprofessional education, Care of impoverished patients, Advancing the role of the pharmacist as a patient care provider

Courses Taught

CPP
5404
ELECTIVE I CLERKSHIP
CPP
5407
AMBULATORY CARE CLERKSHIP
CPP
5412
APPE- KEY CONCEPTS OF PHARM
CPP
5413
APPE - ADVANCED COMMUNITY PHAR
PHR
5108
DRUGS/NEOPLASTIC/ASSOC DISEASE

Select Publications

Journal Articles

Kanmaz, T. J. (2012). Overview of Pancreatic Cancer. U.S. Pharmacist .

Kanmaz, T. J. (2010). Overview and Update for the Management of Human Immunodeficiency Virus (HIV) Infected Adults.. In: America’s Pharmacist: The Voice of the Community Pharmacist.. America's Pharmacist .

Kanmaz, T. J. (2010). Antiretroviral medication knowledge among New York State pharmacists: room for improvement.. Journal of Phar.

Kanmaz, T. J. (2007). HIV-infected Patients Receiving Lopinavir/ritonavir-based Antiretroviral Therapy Achieve High Rates of Virologic Suppression Despite Adherence Rates Below 95%.. Journal of Acquired Immune Deficiency Syndromes.

Others

Kanmaz, T. J. (2010). Recent controversies in cancer screening recommendations: a focus on breast, cervical and prostate cancer. U.S. Pharmacist .